RBM17 Protein (SPF45)
Overview
RBM17, commonly referred to as SPF45 (Splicing Factor, Proline- and Glutamine-rich), is an RNA-binding protein encoded by the RBM17 gene located on chromosome 19p13.3. This approximately 45 kDa protein belongs to the diverse family of RNA recognition motif (RRM)-containing proteins that regulate post-transcriptional gene expression. RBM17/SPF45 was initially characterized for its role in constitutive and alternative splicing, but emerging evidence demonstrates its significance in neuronal function and potential involvement in neurodegenerative disease pathways. The protein contains multiple functional domains including two tandem RRM domains and proline/glutamine-rich regions that facilitate protein-protein interactions and RNA binding specificity.
Function/Biology
RBM17/SPF45 functions as a splicing regulator with dual roles in both the early and late stages of spliceosome assembly and catalysis. The protein localizes predominantly to the nucleus, particularly within nuclear speckles—dynamic structures enriched in splicing factors. Through its RRM domains, RBM17 recognizes specific RNA sequences within pre-mRNA substrates, while its C-terminal proline- and glutamine-rich regions enable interaction with other splicing factors including U2AF65, SF1, and various SR proteins (serine/arginine-rich proteins).
...RBM17 Protein (SPF45)
Overview
RBM17, commonly referred to as SPF45 (Splicing Factor, Proline- and Glutamine-rich), is an RNA-binding protein encoded by the RBM17 gene located on chromosome 19p13.3. This approximately 45 kDa protein belongs to the diverse family of RNA recognition motif (RRM)-containing proteins that regulate post-transcriptional gene expression. RBM17/SPF45 was initially characterized for its role in constitutive and alternative splicing, but emerging evidence demonstrates its significance in neuronal function and potential involvement in neurodegenerative disease pathways. The protein contains multiple functional domains including two tandem RRM domains and proline/glutamine-rich regions that facilitate protein-protein interactions and RNA binding specificity.
Function/Biology
RBM17/SPF45 functions as a splicing regulator with dual roles in both the early and late stages of spliceosome assembly and catalysis. The protein localizes predominantly to the nucleus, particularly within nuclear speckles—dynamic structures enriched in splicing factors. Through its RRM domains, RBM17 recognizes specific RNA sequences within pre-mRNA substrates, while its C-terminal proline- and glutamine-rich regions enable interaction with other splicing factors including U2AF65, SF1, and various SR proteins (serine/arginine-rich proteins).
RBM17 participates in constitutive splicing of housekeeping genes and modulates alternative splicing patterns in response to cellular conditions. Alternative splicing represents a critical mechanism for generating proteomic diversity, with approximately 95% of human multi-exon genes undergoing alternative splicing. RBM17 exhibits preferential binding to polypyrimidine tract regions and influences exon inclusion/exclusion patterns through both cooperative and competitive interactions with other RNA-binding proteins. The protein also displays roles in mRNA stability and localization, suggesting broader post-transcriptional regulatory functions beyond canonical splicing.
Role in Neurodegeneration
Recent research has implicated RBM17/SPF45 dysfunction in several neurodegenerative conditions through disruption of normal splicing patterns and protein homeostasis. In neuronal cells, RBM17 regulates the alternative splicing of genes encoding proteins critical for neuronal function, axonal transport, and synaptic plasticity. Dysregulation of RBM17 activity or expression has been associated with altered splicing of neurodegeneration-related genes, including those encoding tau protein isoforms and amyloid-beta processing enzymes.
Emerging evidence suggests RBM17 dysfunction contributes to pathology in Alzheimer's disease through impaired splicing of transcripts involved in amyloid precursor protein (APP) metabolism and tau regulation. Similarly, in Parkinson's disease, altered RBM17-mediated splicing may influence α-synuclein isoform production and mitochondrial function genes. The protein may also play roles in ALS pathogenesis through effects on motor neuron-specific gene expression patterns.
Molecular Mechanisms
RBM17/SPF45 exerts neurodegeneration-relevant effects through several interconnected mechanisms. First, the protein modulates splicing of genes encoding molecular chaperones, proteasomal components, and autophagy machinery—all critical for maintaining proteostasis and clearing misfolded proteins. Second, RBM17 regulates alternative splicing of neurotrophic signaling pathways and genes involved in mitochondrial function and energy metabolism.
The protein also influences splicing of genes encoding RNA-binding proteins themselves, creating potential regulatory networks where RBM17 dysfunction cascades through the RNA-binding protein landscape. Additionally, RBM17 interacts with stress-response pathways, with evidence suggesting its activity changes under cellular stress conditions typical of neurodegeneration, including oxidative stress and endoplasmic reticulum stress.
Post-translational modifications of RBM17, including phosphorylation and ubiquitination, regulate its splicing activity and subcellular localization, providing additional layers of regulation that may become dysregulated in disease states.
Clinical/Research Significance
Understanding RBM17/SPF45 function holds therapeutic potential for neurodegenerative diseases, particularly regarding splicing modulation strategies. Research has identified connections between RBM17 expression levels and alternative splicing patterns in postmortem brain tissue from Alzheimer's disease and other neurodegenerative patients. Targeting RBM17 activity or modulating its protein interactions represents a novel therapeutic avenue for correcting pathogenic splicing patterns.
- SRSF1-SRSF12 (SR proteins)
- U2AF65/35 (U2 auxiliary factors)
- SNRPB (spliceosomal component)
- PRPF40A (pre-mRNA processing factor)
- hnRNP family (heterogeneous nuclear ribonucleoproteins)
- Alternative splicing disorders
- Proteostasis mechanisms